A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/155 (2006.01) A61K 31/485 (2006.01) A61P 29/00 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2739936
Pharmaceutical compositions and their methods of use are provided, where the pharmaceutical compositions comprise a phenolic opioid prodrug that provides enzymatically-controlled release of a phenolic opioid, and an enzyme inhibitor that interacts with the enzyme(s) that mediates the enzymatically-controlled release of the phenolic opioid from the prodrug so as to attenuate enzymatic cleavage of the prodrug.
L'invention porte sur des compositions pharmaceutiques et sur leurs procédés d'utilisation. Les compositions pharmaceutiques comprennent un promédicament opioïde phénolique qui permet une libération contrôlée enzymatiquement d'un opioïde phénolique, et un inhibiteur d'enzyme qui interagit avec la ou les enzymes qui servent de médiateur à la libération contrôlée enzymatiquement de l'opioïde phénolique à partir du promédicament de façon à atténuer un clivage enzymatique du promédicament.
Jenkins Thomas E.
Seroogy Julie D.
Wray Jonathan W.
Pharmacofore Inc.
Smart & Biggar
LandOfFree
Pharmaceutical compositions with attenuated release of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions with attenuated release of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions with attenuated release of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1548678